Clinical research studyDramatic Reversal of Derangements in Muscle Metabolism and Left Ventricular Function After Bariatric Surgery
Section snippets
Subject Selection
We offered participation to patients of any race/ethnicity from the University of Texas Houston Bariatric Surgery Center who met the inclusion criteria for bariatric surgery outlined previously.13 Exclusion criteria were coronary artery disease, ischemic cardiomyopathy, severe peripheral vascular disease, a current history of smoking, pregnancy, or an age of less than 18 years. The study was approved by the Committee for the Protection Human Subjects at The University of Texas Health Science
Preoperative Findings
Table 1 lists the baseline characteristics of all patients, the patients undergoing SPGB, and the patients undergoing LAGB. There were no significant differences in the baseline characteristics between the 2 surgical groups for any of the variables measured. Patients had more fat mass than lean body mass at baseline, as measured by bioelectrical impedance analysis (Table 1). Mean blood pressure and heart rates were in the normal range. Almost all of the patients met criteria for insulin
Discussion
The main findings of our study are that weight loss induced by surgery is accompanied by a reversal of insulin resistance and dramatic changes in skeletal muscle metabolism. The former findings were expected, but the latter findings are new. Adipose tissue is an active endocrine organ, and an increased adipose mass is associated with insulin resistance and alterations of fatty acid oxidation by complex mechanisms.22, 23 These effects are mediated by adipose-derived hormones and cytokines (eg,
Limitations
We are excited about the findings, but we also are aware of the following limitations. First, this is a small prospective, longitudinal observational study, and we can only infer a relationship between the outcomes, not prove a causal relationship. Larger studies using external controls are needed to define the true relationships among skeletal muscle gene expression, systemic metabolism, and contractile function of the heart. Second, gene expression does not necessarily reflect protein content
Conclusions
Nonpharmacologic weight loss induced by bariatric surgery results in an early reversal of the maladaptive responses to obesity. Leptin resistance and insulin resistance reverse, leading to improved systemic metabolism and skeletal muscle gene expression. It is possible that these mechanisms also may exert a positive effect on left ventricular diastolic function. The implications of these findings for freedom from comorbidities of obesity remain to be substantiated by the long-term follow-up of
Acknowledgments
The authors acknowledge the following contributors: Carol Wolin-Riklin, RN, University of Texas at Houston General Clinical Research Center, and Charles Majka, BS, University of Texas Houston Medical School for data collection; Rebecca L. Salazar, BS, University of Texas Houston Medical School Department of Medicine, for technical assistance. We thank Roxy A. Tate for expert editorial help.
References (39)
- et al.
Improvements in systemic metabolism, anthropometrics, and left ventricular geometry 3 months after bariatric surgery
Surg Obes Relat Dis
(2006) Bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers
J Am Coll Surg
(2005)- et al.
Association of newer diastolic function parameters with age in healthy subjects: a population-based study
J Am Soc Echocardiogr
(2003) - et al.
Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans
Cell Metab
(2005) - et al.
Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging
J Am Coll Cardiol
(2004) - et al.
Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline
J Am Coll Cardiol
(2003) - et al.
Association of plasma free fatty acids and left ventricular diastolic function in patients with clinically severe obesity
Am J Clin Nutr
(2006) - et al.
Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart
J Biol Chem
(2001) - et al.
Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old
N Engl J Med
(2006) Fat in all the wrong places
Nature
(2002)
Regulation of fatty acid homeostasis in cells: novel role of leptin
Proc Natl Acad Sci U S A
Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart
Diabetes
Cellular mechanisms of insulin resistance
J Clin Invest
Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart
FASEB J
Obesity and the risk of heart failure
N Engl J Med
National medical spending attributable to overweight and obesity: how much, and who's paying?
Health Aff (Millwood)
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
N Engl J Med
Effects of bariatric surgery on mortality in Swedish obese subjects
N Engl J Med
Long-term mortality after gastric bypass surgery
N Engl J Med
Cited by (82)
Bariatric Weight Loss Surgery Improves Systolic Function in Obese Patients With Heart Failure
2023, Current Problems in CardiologyThe role of weight control in the management of type 2 diabetes mellitus: Bariatric surgery
2023, Diabetes Research and Clinical PracticeObesity and Heart Failure with Preserved Ejection Fraction
2021, Heart Failure ClinicsHeart failure management; a perspective from diabetes care
2021, Diabetes Research and Clinical PracticeTherapeutic Manipulation of Myocardial Metabolism: JACC State-of-the-Art Review
2021, Journal of the American College of Cardiology
Supported by the National Heart, Lung, and Blood Institute of the US Public Health Service (R01HL73162 and M01 RR02558). None of the authors of this work have any financial conflicts of interest to disclose. All authors had access to the data and a role in writing the article.
Clinical Trials Registry: ClinicalTrials.gov Identifier: NCT00178633; http:/www.clinicaltrials.gov